$18.72
0.432.35%
Last update: Oct 27, 6:40 PM
Viatris Inc (VTRS) Stock Price, Quote, News & History
VTRSNASDAQ
Pacira BioSciences stock surges 44% after Viatris announces a $1.65 billion takeover deal to expand its pain treatment portfolio.
You can purchase shares of Viatris (NASDAQ:VTRS) through any online brokerage.
Other companies in Viatris’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Viatris has a consensus price target of $17.23.
The stock price for Viatris (NASDAQ: VTRS) is $18.8 last updated October 27, 2026 at 6:40 PM EDT.
There are no upcoming dividends for Viatris.
Viatris does not have any upcoming earnings scheduled.
There is no upcoming split for Viatris.
Viatris is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining...
